NU Skin Enterprises Inc

The asset is firmly in a Stage 4 decline with dominant lower highs and lower lows, down-trending moving averages, and persistent distribution. Medium-term bias is bearish, supported by structural downtrend and bearish pattern implications. Short-term price has attempted a bounce but was rejected at falling EMAs, indicating execution readiness for selling. The long-term secular trend remains negative. Risks include possible oversold mean-reversion bounces and a reclaim of EMAs that could signal a reversal.

• ↑Dividend yield of 4.9% exceeds industry average, boosting income.
• ↑High earnings yield suggests attractive valuation versus peers.
• ↓Negative profitability metrics point to low margin conversion.